Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers from Northwestern University publish new studies and findings in the area of breast cancer
May 7th, 2009
"Effective methods of serial epithelial sampling to measure breast-specific biomarkers will aid the rapid evaluation of new preventive interventions. We report here a proof-of-principle phase 2 study to assess the utility of ductal lavage (DL) to measure biomarkers of tamoxifen action," scientists in the United States report. "We enrolled women with a 5-year breast cancer risk estimate > 1.6% or the unaffected breast of women with T-1a or T-1b breast cancer. After entry DL, participants chose tamoxifen or observation and underwent repeat DL 6 months later. Samples were processed for cytology and immunohistochemistry for estrogen receptor a, Ki-67, and...
Source: Women's Health Weekly (2009-05-07)
|
